MELBOURNE, Australia--(BUSINESS WIRE)--June 16, 2006--Genetic Technologies Limited ("GTG") (NASDAQ:GENE - News; ASX:GTG - News) is pleased to announce that it has executed a Memorandum of Understanding with Analytical Reference Laboratories Pty. Ltd. ("ARL Pathology") under which GTG will provide molecular diagnostic services across ARL Pathology's extensive pathology network.
